Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RXRA | P19793 | 1/20 | 0.30 |
| ▸ | RXRB | P28702 | 1/20 | 0.30 |
| ▸ | RXRG | P48443 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15129781 | 0.99 | RXRA (0.30) | RXRARXRBRXRG | |
| SCHEMBL114709 | 0.96 | RXRA (0.31) | RXRARXRBRXRG | |
| SCHEMBL136845 | 0.96 | RXRA (0.31) | RXRARXRBRXRG | |
| SCHEMBL29017325 | 0.95 | RXRA (0.30) | RXRARXRBRXRG | |
| SCHEMBL9929142 | 0.95 | RXRA (0.30) | RXRARXRBRXRG | |
| Potassium SCHEMBL9929144 | 0.95 | RXRA (0.30) | RXRARXRBRXRG | |
| SCHEMBL24284312 | 0.88 | — | — | |
| SCHEMBL560019 | 0.88 | CA2 (0.31) | RXRARXRBRXRG | |
| SCHEMBL10037955 | 0.87 | S1PR3 (0.36) | RXRARXRBRXRG | |
| SCHEMBL13264906 | 0.85 | CYP26B1 (0.35) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 73 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11834489-B2 | Methods for quantifying ligand efficacy in G-protein coupled receptors using single-molecule fluorescence energy transfer | CORNELL UNIVERSITY (US) | 2023-12-05 | — | — | US | disclosed |
| EP-3773750-B1 | FORMULATION AND METHOD OF PREPARATION | GE HEALTHCARE AS (NO) | 2022-04-20 | — | — | EP | disclosed |
| US-20210046195-A1 | FORMULATION AND METHOD OF PREPARATION | GE HEALTHCARE AS (NO) | 2021-02-18 | — | — | US | disclosed |
| US-20210046195-A1 | FORMULATION AND METHOD OF PREPARATION | GE HEALTHCARE AS (NO) | 2021-02-18 | — | — | US | disclosed |
| CN-112203698-A | Preparation and preparation method | 通用电气医疗集团股份有限公司 | 2021-01-08 | — | — | CN | disclosed |
| US-9631096-B2 | Dye compositions, methods of preparation, conjugates thereof, and methods of use | CORNELL UNIVERSITY (US) | 2017-04-25 | — | — | US | disclosed |
| US-9110069-B2 | Luminescent compounds | SETA BIOMEDICALS, LLC (US) | 2015-08-18 | — | — | US | disclosed |
| US-9110069-B2 | Luminescent compounds | SETA BIOMEDICALS, LLC (US) | 2015-08-18 | — | — | US | disclosed |
| US-20150011731-A1 | DYE COMPOSITIONS, METHODS OF PREPARATION, CONJUGATES THEREOF, AND METHODS OF USE | CORNELL UNIVERSITY (US) | 2015-01-08 | — | — | US | disclosed |
| US-20140086844-A1 | LUMINESCENT COMPOUNDS | SETA BIOMEDICALS, LLC (US) | 2014-03-27 | — | — | US | disclosed |
| US-20070203343-A1 | Cyanine Dye Labelling Reagents | GE HEALTHCARE UK LIMITED (GB) | 2007-08-30 | — | — | US | disclosed |
| US-20070203343-A1 | Cyanine Dye Labelling Reagents | GE HEALTHCARE UK LIMITED (GB) | 2007-08-30 | — | — | US | disclosed |
| US-20060239922-A1 | WATER-SOLUBLE FLUORO-SUBSTITUTED CYANINE DYES AS REACTIVE FLUORESCENCE LABELLING REAGENTS | GE HEALTHCARE UK LIMITED (GB) | 2006-10-26 | — | — | US | disclosed |
| WO-2006111726-A1 | WATER SOLUBLE FLUORO-SUBSTITUTED CYANINE DYES AS REACTIVE FLUORESCENCE LABELLING REAGENTS | GE HEALTHCARE UK LIMITED (GB) | 2006-10-26 | — | — | WO | disclosed |
| EP-1678258-A1 | CYANINE DYE LABELLING REAGENTS | GE Healthcare Limited (GB) | 2006-07-12 | — | — | EP | disclosed |
| US-20060051758-A1 | Chiral indole intermediates and their fluorescent cyanine dyes containing functional groups | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2006-03-09 | — | — | US | disclosed |
| EP-1525265-A4 | CHIRAL INDOLE INTERMEDIATES AND THEIR FLUORESCENT CYANINE DYES CONTAINING FUNCTIONAL GROUPS | UNIV CARNEGIE MELLON (US) | 2005-06-22 | — | — | EP | disclosed |
| WO-2005044923-A1 | CYANINE DYE LABELLING REAGENTS | GE HEALTHCARE LIMITED (GB) | 2005-05-19 | — | — | WO | disclosed |
| EP-1525265-A2 | CHIRAL INDOLE INTERMEDIATES AND THEIR FLUORESCENT CYANINE DYES CONTAINING FUNCTIONAL GROUPS | CARNEGIE-MELLON UNIVERSITY (US) | 2005-04-27 | — | — | EP | disclosed |
| WO-2004039894-A2 | CHIRAL INDOLE INTERMEDIATES AND THEIR FLUORESCENT CYANINE DYES CONTAINING FUNCTIONAL GROUPS | CARNEGIE MELLON UNIVERSITY (US) | 2004-05-13 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210046195-A1 | FORMULATION AND METHOD OF PREPARATION | IAPP, LPXN, KIT | RXRA 3815/4885RXRB 3195/4885RXRG 3093/4885 |
| US-20140086844-A1 | LUMINESCENT COMPOUNDS | PHOSPHO1, PGLS, PFAS | RXRA 4546/4885RXRB 4432/4885RXRG 4665/4885 |
| US-20060051758-A1 | Chiral indole intermediates and their fluorescent cyanine dyes containing functional groups | IDO1, TDO2, IDO2 | RXRA 2790/4885RXRB 2980/4885RXRG 2264/4885 |
| US-20060239922-A1 | WATER-SOLUBLE FLUORO-SUBSTITUTED CYANINE DYES AS REACTIVE FLUORESCENCE LABELLING REAGENTS | TPD52L2, MRPL21, MRPL9 | RXRA 1256/4885RXRB 1103/4885RXRG 1188/4885 |
| US-20070203343-A1 | Cyanine Dye Labelling Reagents | IK, H1-5, H1-3 | RXRA 1726/4885RXRB 1654/4885RXRG 1474/4885 |
| US-11834489-B2 | Methods for quantifying ligand efficacy in G-protein coupled receptors using single-molecule fluorescence energy transfer | GPR3, GPR4, GPR68 | RXRA 1032/4885RXRB 873/4885RXRG 638/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.